Multiple sclerosis
Title Filter     Display # 
# Article Title
1 Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of ch
2 Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a random
3 Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
4 Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis.
5 Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multi
6 European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfe
7 Increased blood plasma concentrations of TGF-beta isoforms after treatment with intravenous immunogl
8 Increased blood plasma concentrations of TGF-beta isoforms after treatment with intravenous immunogl
9 Intravenous immunoglobulin and mitoxantrone stop the progression of secondary progressive multiple s
10 A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination w
11 The role of qualitative and quantitative MRI assessment of multiple sclerosis lesions according to t
12 Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlle
13 Regulation of self-reactive T cells by human immunoglobulins--implications for multiple sclerosis th
14 Contrasting effects of IFNbeta and IVIG in children with central and peripheral demyelination.
15 [Intravenous immunoglobulins for relapsing-remitting multiple sclerosis after failure of treatment w
16 [Intravenous immunoglobulin in multiple sclerosis]
17 Intravenous immunoglobulins for multiple sclerosis.
18 Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
19 The role of intravenous immunoglobulin in the treatment of multiple sclerosis.
20 Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-ana
 
<< Start < Prev 1 2 Next > End >>
Page 1 of 2